We Help Companies Find New Sales Opportunities
Sinclair Pharma and IS Pharma are in merger discussions that would lead to the creation of a pan-European speciality pharmaceuticals group called Sinclair IS Pharma.
Sinclair Pharma has acquired Cranage Healthcare, the Cheshire-based distributor of woundcare products, for an initial £0.4m.
Sinclair Pharma has acquired the Flammazine and Flammacerium dermatology products from Solvay Pharmaceuticals for £16m.
Sinclair Pharma is to acquire Ashbourne Pharmaceuticals, the Northampton-based pharmaceuticals marketing company, for £1.3m.
Sinclair Pharmaceuticals is to acquire Group CS Dermatologie, the French skincare company, for £37m.
Sinclair Pharma is to acquire Euroderm, the Italian supplier of dermatology pharmaceuticals with 33 staff, for £4.2m.
Sinclair Pharmaceuticals has raised £22m in a share placing to fund the expansion of its drug development business.